Matthew W. Strobeck

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Matthew W. Strobeck

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Employee Restricted Stock Units
Shares / value
236,842
Estimated value
$1,039,736
Report date
28 Jun 2023
Price
$4.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
120,682
Estimated value
$529,794
Report date
23 Jan 2024
Price
$4.39
Ownership
By Birchview Fund, LLC
Form 4 holding Director

BIODESIX INC

Security class
Restricted Stock Units
Shares / value
6,804
Estimated value
$22,565
Report date
02 Jan 2026
Price
$0.4200
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
2,000
Estimated value
$8,780
Report date
23 Jan 2024
Price
$4.39
Ownership
As UGMA Custodian for minor children
Form 4 holding Director

QuidelOrtho Corp

Security class
Restricted Stock Units (Equity Grant)
Shares / value
0
Estimated value
$0
Report date
29 May 2026
Price
$39.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock Warrants (right to buy)
Shares / value
100,000
Estimated value
Report date
23 Jan 2024
Price
Ownership
By Birchview Fund, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BIODESIX INC

Security class
Stock Options (Right to Buy)
Shares / value
6,354
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Common Stock
Shares / value
0
Estimated value
Report date
27 May 2022
Price
$15.73
Ownership
Birchview
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Common Stock
Shares / value
0
Estimated value
Report date
27 May 2022
Price
$15.73
Ownership
Direct
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Common Stock
Shares / value
0
Estimated value
Report date
27 May 2022
Price
$15.73
Ownership
UGMA Account
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Non-Qualified Stock Options
Shares / value
0
Estimated value
Report date
27 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
27 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

QUIDEL CORP /DE/

Security class
Restricted Stock Units (Equity Grant)
Shares / value
0
Estimated value
Report date
18 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Matthew W. Strobeck

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .